HealthDay - SUNDAY, March 14 (HealthDay News) -- A new drug called mipomersen
reduced low-density lipoprotein (LDL) "bad" cholesterol by nearly 25
percent when added to current therapy in people with a rare genetic
condition that causes extremely high cholesterol, a new study finds.

More: - Read More